A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

NCT06848231 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy

Interventions

DRUG: YA-101
DRUG: Placebo

Sponsor

Dasher Neuroscience Inc.